Literature DB >> 2016219

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.

R A King1, M A Riddle, P B Chappell, M T Hardin, G M Anderson, P Lombroso, L Scahill.   

Abstract

Self-injurious ideation or behavior appeared de novo or intensified during fluoxetine treatment of obsessive-compulsive disorder in six patients, age 10 to 17 years old, who were among 42 young patients receiving fluoxetine for obsessive-compulsive disorder at a university clinical research center. These symptoms required the hospitalization of four patients. Before receiving fluoxetine, four patients had major risk factors for self-destructive behavior including depression or prior suicidal ideation or self-injury. Three hypotheses concerning the apparent association between fluoxetine and these self-injurious phenomena are discussed: (1) coincidence; (2) disorganization of vulnerable individuals secondary to drug-induced activation; and (3) a specific serotonergic-mediated effect on the regulation of aggression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016219     DOI: 10.1097/00004583-199103000-00003

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  34 in total

1.  Violent acts associated with fluvoxamine treatment.

Authors:  F Okada; K Okajima
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

Review 2.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

Review 3.  Antidepressants and suicide: risk-benefit conundrums.

Authors:  David Healy; Chris Whitaker
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

Review 4.  Suicidality with selective serotonin reuptake inhibitors: Valid claim?

Authors:  Yvon D Lapierre
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

Review 5.  Efficacy and safety of antidepressants for children and adolescents.

Authors:  Jon N Jureidini; Christopher J Doecke; Peter R Mansfield; Michelle M Haby; David B Menkes; Anne L Tonkin
Journal:  BMJ       Date:  2004-04-10

6.  Antidepressants and adverse effects in young patients: uncovering the evidence.

Authors:  Andrew Herxheimer; Barbara Mintzes
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

7.  Toxicological findings in suicides - frequency of antidepressant and antipsychotic substances.

Authors:  Maximilian Methling; Franziska Krumbiegel; Sven Hartwig; Maria K Parr; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2018-11-05       Impact factor: 2.007

Review 8.  Risk of adverse behavioral effects with pediatric use of antidepressants.

Authors:  Wayne K Goodman; Tanya K Murphy; Eric A Storch
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

9.  Safe use of SSRIs in young adults: how strong is evidence for new suicide warning?

Authors:  Michael F Grunebaum; J John Mann
Journal:  Curr Psychiatr       Date:  2007-11

10.  The Fluoxetine and Suicide Controversy : A Review of the Evidence.

Authors:  D Healy
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.